Start › Wrzodziejące zapalenie jelita grubego › Nowy Jork › New York City
Badania kliniczne dla Wrzodziejące zapalenie jelita grubego w mieście New York City, NY
23 badań dla Wrzodziejące zapalenie jelita grubego szuka uczestników w ośrodkach w mieście New York City i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekrutacjaFaza 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekrutacjaFaza 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekrutacjaFaza 3
- New York Gastroenterology Associates ( Site 0253), New York
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekrutacjaFaza 2
- Pioneer Clinical Research NY, New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekrutacjaFaza 4
- New York Gastroenterology Associates, New York
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekrutacjaFaza 2
- Site 037, New York
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
RekrutacjaFaza 3
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medical College, New York
- i 2 więcej
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RekrutacjaFaza 2/3
- Columbia University Medical Center, New York
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekrutacjaFaza 3
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RekrutacjaFaza 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RekrutacjaFaza 4
- NYU Langone Health, New York
- Weill Cornell Medical College- New York Presbyterian Hospital, New York
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekrutacjaFaza 3
- Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- New York Gastroenterology Associates - Site Number: 8400009, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RekrutacjaFaza 3
- New York Gastroenterology Associates, New York
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
RekrutacjaFaza 2
- Fink Children's Ambulatory Care Center, New York
- Kimmel Pavilion - NYU Langone, New York
- NYU Grossman School of Medicine, New York
- i 4 więcej
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
RekrutacjaFaza 2
- Columbia University Medical Center, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekrutacjaFaza 3
- Manhattan Clinical Research, LLC - Site Number: 8400069, New York
- NYU Langone Health - Site Number: 8400091, New York
- Weill Cornell Medical College - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- i 2 więcej
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Rekrutacja
- NYU Langone Health, New York
- Cornell University, New York
BOOM-IBD2 Pivotal Clinical Trial
Rekrutacja
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RekrutacjaBadanie obserwacyjne
- New York University, New York
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RekrutacjaBadanie obserwacyjne
- NYU Langone Health, New York
- Lenox Hill Hospital, Northwell Health, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RekrutacjaFaza 3
- New York Presbyterian Hospital, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekrutacjaFaza 2
- Mirador Therapeutics Selected Site, New York
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RekrutacjaBadanie obserwacyjne
- New York University, New York
Badania dla Wrzodziejące zapalenie jelita grubego w innych miastach
- Orlando, FL22 badań
- Miami, FL21 badań
- Houston, TX17 badań
- San Antonio, TX16 badań
- Tyler, TX15 badań
- Tacoma, WA15 badań
- Chicago, IL15 badań
- San Diego, CA15 badań
- Colorado Springs, CO14 badań
- Los Angeles, CA13 badań
- St. Louis, MO13 badań
- Washington, DC12 badań
Inne badania w mieście New York City
- Rak piersi136 badań
- Niedrobnokomórkowy rak płuca121 badań
- Nowotwory (wszystkie typy)109 badań
- Rak prostaty103 badań
- Nowotwór przerzutowy93 badań
- Rak jelita grubego i odbytnicy78 badań
- Rak jajnika69 badań
- Rak płuc60 badań
- Szpiczak mnogi60 badań
- Rak trzustki60 badań
- Rak endometrium52 badań
- Ostra białaczka szpikowa51 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.